• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和生物评价 ⁹⁹mTc-磺酰胺衍生物作为替代肿瘤乏氧标志物 CAIX 的体内可视化探针。

Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.

机构信息

Laboratory of Radiopharmacy, KU Leuven, Leuven, Belgium.

Department of Radiation Oncology (Maastro Lab), GROW - School for Oncology and Development Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands.

出版信息

Eur J Med Chem. 2014 Jan;71:374-84. doi: 10.1016/j.ejmech.2013.10.027. Epub 2013 Oct 30.

DOI:10.1016/j.ejmech.2013.10.027
PMID:24378650
Abstract

In vivo visualization of tumor hypoxia related markers, such as the endogenous transmembrane protein CA IX may lead to novel therapeutic and diagnostic applications in the management of solid tumors. In this study 4-(2-aminoethyl)benzene sulfonamide (AEBS, K(i) = 33 nM for CA IX) has been conjugated with bis(aminoethanethiol) (BAT) and mercaptoacetyldiglycine (MAG2) tetradendate ligands and the conjugates radiolabelled with (99m)Tc, to obtain anionic and neutral (99m)Tc-labeled sulfonamide derivatives, respectively. The corresponding rhenium analogues were also prepared and showed good inhibitory activities against hCA IX (K(i) = 59-66 nM). In addition, a second generation bis AEBS was conjugated with MAG2 and labeled with (99m)Tc, and the obtained diastereomers were also evaluated in targeting CA IX. Biodistribution studies in mice bearing HT-29 colorectal xenografts revealed a maximum tumor uptake of <0.5% ID/g at 0.5 h p.i for all the tracers. In vivo radiometabolite analysis indicated that at 1 h p.i. MAG₂ tetradendate ligands were more stable in plasma (>50% intact) compared to the neutral complex (28% intact). This preliminary data suggest that negatively charged (99m)Tc-labeled sulfonamide derivatives with modest lipophilicity and longer circulation time could be promising markers to target CA IX.

摘要

在体可视化肿瘤乏氧相关标志物,如内源性跨膜蛋白 CAIX,可能导致新的治疗和诊断应用于实体瘤的治疗。在这项研究中,4-(2-氨乙基)苯磺酰胺(AEBS,对 CAIX 的 K(i) = 33 nM)已与双(氨乙基硫醇)(BAT)和巯基乙酰二甘氨酸(MAG2)四齿配体缀合,并分别用(99m)Tc 放射性标记缀合物,得到阴离子和中性(99m)Tc 标记的磺酰胺衍生物。相应的铼类似物也被制备出来,并显示出对 hCA IX 的良好抑制活性(K(i) = 59-66 nM)。此外,第二个第二代双 AEBS 与 MAG2 缀合并用(99m)Tc 标记,所得到的非对映异构体也用于靶向 CA IX。在携带 HT-29 结肠直肠癌异种移植的小鼠中进行的生物分布研究表明,所有示踪剂在 0.5 h p.i.时的最大肿瘤摄取率<0.5% ID/g。体内放射性代谢物分析表明,在 1 h p.i.时,MAG₂四齿配体在血浆中的稳定性更高(>50%完整),而中性复合物(28%完整)。这些初步数据表明,带负电荷的(99m)Tc 标记的磺酰胺衍生物具有适度的亲脂性和更长的循环时间,可能是靶向 CA IX 的有前途的标志物。

相似文献

1
Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.开发和生物评价 ⁹⁹mTc-磺酰胺衍生物作为替代肿瘤乏氧标志物 CAIX 的体内可视化探针。
Eur J Med Chem. 2014 Jan;71:374-84. doi: 10.1016/j.ejmech.2013.10.027. Epub 2013 Oct 30.
2
Evaluation of Tc-sulfonamide and sulfocoumarin derivatives for imaging carbonic anhydrase IX expression.评估 Tc-磺酰胺和磺基香豆素衍生物用于成像碳酸酐酶 IX 表达。
J Inorg Biochem. 2018 Aug;185:63-70. doi: 10.1016/j.jinorgbio.2018.04.009. Epub 2018 Apr 13.
3
Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.99mTc 标记磺酰胺缀合物的合成及生物评价用于肿瘤低氧中碳酸酐酶 IX 表达的体内可视化。
Nucl Med Biol. 2010 Jul;37(5):557-64. doi: 10.1016/j.nucmedbio.2010.02.006. Epub 2010 Apr 24.
4
Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.用于实现碳酸酐酶IX靶向PET成像体内选择性的三聚体放射性氟化磺酰胺衍生物
J Nucl Med. 2015 Sep;56(9):1434-40. doi: 10.2967/jnumed.114.153288. Epub 2015 Jul 23.
5
Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.新型 Re/99mTc 标记苯磺酰胺碳酸酐酶 IX 抑制剂的合成及构效关系研究及其用于肿瘤乏氧的分子成像。
J Med Chem. 2013 Jan 24;56(2):510-20. doi: 10.1021/jm3015348. Epub 2013 Jan 8.
6
PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.用(68)Ga标记的苯磺酰胺对HT-29肿瘤异种移植小鼠碳酸酐酶IX表达进行正电子发射断层显像
Mol Pharm. 2016 Mar 7;13(3):1137-46. doi: 10.1021/acs.molpharmaceut.5b00934. Epub 2016 Feb 19.
7
Synthesis and evaluation of novel technetium-99m-hydroxamamide complex based on imidazothiadiazole sulfonamide targeting carbonic anhydrase-IX for tumor imaging.新型基于咪唑并噻二唑磺酰胺的锝-99m 羟基酰胺配合物的合成与评价,用于碳酸酐酶-IX 靶向肿瘤成像。
Bioorg Med Chem Lett. 2020 Nov 15;30(22):127596. doi: 10.1016/j.bmcl.2020.127596. Epub 2020 Oct 1.
8
Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.(18)F 标记的三级苯磺酰胺类化合物的合成与评价及其用于正电子发射断层扫描成像肿瘤中碳酸酐酶 IX 的表达。
Bioorg Med Chem Lett. 2014 Jul 15;24(14):3064-8. doi: 10.1016/j.bmcl.2014.05.021. Epub 2014 May 17.
9
Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.靶向碳酸酐酶IX的磺胺类衍生物作为体内检测结直肠癌的核成像探针。
Oncotarget. 2015 Nov 3;6(34):36139-55. doi: 10.18632/oncotarget.5684.
10
Development of the Tc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX.作为靶向碳酸酐酶 IX 的探针的 Tc-羟肟酸配合物的研制。
Mol Pharm. 2019 Apr 1;16(4):1489-1497. doi: 10.1021/acs.molpharmaceut.8b01120. Epub 2019 Mar 20.

引用本文的文献

1
Metal complexes of sulfamethazine/benzoin-based Schiff base ligand: synthesis, characterization, DFT calculations, and antimicrobial activities.磺胺二甲嘧啶/安息香基席夫碱配体的金属配合物:合成、表征、密度泛函理论计算及抗菌活性
Turk J Biol. 2024 Dec 24;49(1):118-126. doi: 10.55730/1300-0152.2729. eCollection 2025.
2
Synthesis and antibacterial evaluation of quinoline-sulfonamide hybrid compounds: a promising strategy against bacterial resistance.喹啉-磺酰胺杂化化合物的合成与抗菌评价:一种对抗细菌耐药性的有前景的策略。
RSC Adv. 2025 Jan 17;15(3):1680-1689. doi: 10.1039/d4ra05069j. eCollection 2025 Jan 16.
3
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.
小分子碳酸酐酶 IX 靶向 PET 示踪剂在肾透明细胞癌的临床前和初步临床评估。
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3116-3125. doi: 10.1007/s00259-023-06248-7. Epub 2023 May 29.
4
Toxicity Assessment of an Anti-Cancer Drug of p-Toluene Sulfonamide in Zebrafish Larvae Based on Cardiovascular and Locomotion Activities.基于心血管和运动活动的对甲苯磺酰胺类抗癌药物对斑马鱼幼鱼的毒性评估。
Biomolecules. 2022 Aug 10;12(8):1103. doi: 10.3390/biom12081103.
5
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.基于双价脲基磺酰胺的 US2 平台的碳酸酐酶-IX 高表达肿瘤的 PET 成像和药物靶向治疗。
PLoS One. 2020 Dec 9;15(12):e0243327. doi: 10.1371/journal.pone.0243327. eCollection 2020.
6
Development of a Ga-labelled PET tracer for carbonic anhydrase IX-overexpressed tumors using the artificial sweetener saccharin.利用人工甜味剂糖精开发用于碳酸酐酶 IX 过表达肿瘤的 Ga 标记 PET 示踪剂。
J Labelled Comp Radiopharm. 2021 Mar;64(3):129-139. doi: 10.1002/jlcr.3893. Epub 2020 Nov 9.
7
Pharmaceutical and medicinal significance of sulfur (S)-Containing motifs for drug discovery: A critical review.含硫(S)结构在药物研发中的药用和药物学意义:批判性评价。
Eur J Med Chem. 2019 Jan 15;162:679-734. doi: 10.1016/j.ejmech.2018.11.017. Epub 2018 Nov 22.
8
Cancer radiotheranostics targeting carbonic anhydrase-IX with In- and Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy.基于铟和钇标记的脲基磺酰胺支架的碳酸酐酶-IX 导向癌症放诊治,用于 SPECT 成像和基于放射性核素的治疗。
Theranostics. 2018 Apr 30;8(11):2992-3006. doi: 10.7150/thno.20982. eCollection 2018.
9
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.过去、现在和未来:靶向碳酸酐酶 IX 的治疗药物研发。
Theranostics. 2017 Sep 26;7(17):4322-4339. doi: 10.7150/thno.21848. eCollection 2017.
10
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.碳酸酐酶抑制与缺氧肿瘤的治疗
Metabolites. 2017 Sep 16;7(3):48. doi: 10.3390/metabo7030048.